ClinicalTrials.gov
public full text
Public Domain
A Phase 1 Study of HCB303 in Participants With Advanced Malignancies
A Phase 1, Open-label, Multi-regional, Multicenter, Dose escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Antitumor Activity of HCB303 in Participants with Advanced Malignancies
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors#1150572
- SCTB41 Plus SCTB39G With or Without Standard Therapy in Advanced Solid Tumors#884151
- Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors#968503
- A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma#893417
- A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies#1196922
Record · ID 1211749
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive